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ABSTRACT 
Background: Occult hepatitis B infection (OBI) is simply defined as serologically undetectable 
hepatitis B surface antigen (HBsAg-ve), despite the presence of circulating HBV DNA.  
Objective: The aim of this study was to determine the prevalence of occult HBV among Screened 
HBsAg subjects in Gezira State, Sudan.  
Materials and Methods: A total of 176 subjects including cancer patients, hospital based controls 
and health care workers were screened for HBsAg by ELISA, and their DNA was extracted by 
using polymerase chain reaction.  
Results: 49/176 (27.8%) were positive for occult HBV as follows: cancer patients had 31/81 
(38.2%) cases, while 18.9% were reported among hospital based controls. 11.2%, 2.2% were 
positive for both HBsAg and DNA respectively. Ten out of the 50 (20%) healthcare workers, who 
were negative for HBsAg, were found to be positive for HBV DNA, while one out of the 19, who 
were positive for HBsAg, was found to be positive for HBV DNA. Occult HBV among this study 
groups showed an approximately equal distribution among males and females 18.2% and 20.5 %, 
respectively.  
Conclusion: This study concluded that the prevalence of OBI among healthcare workers, hospital 
based controls and cancer patients, is remarkably increasing compared with the prevalence of the 
disease. More molecular epidemiological studies are needed to delineate a link between OBI and 
cancer. Proper HBV screening should be carried out to avoid occult hepatitis B infection 
transmission. 
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epatitis B virus(HBV) remains a 
major public health problem 
worldwide1. Implementation of 
hepatitis B surface antigen (HBsAg) in 
routine screening of blood donors in the early 
1970s has greatly enhanced transfusion 
safety2. The incidence of transfusion-
transmitted hepatitis B has steadily reduced 
over the last decades2.  
However, it was demonstrated that HBV 
transmission by blood components 
negative for HBsAg can still occur3. Hence 
the term occult hepatitis B virus infection 
(OBI) was introduced.OBI is simply defined 
as serologically undetectable hepatitis B 
surface   antigen   (HBsAg-ve),   despite    the 
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presence of circulating HBV DNA4,5. The 
residual risk of HBV transfusion transmission 
is mainly related to blood donations negative 
for HBsAg that have been collected either 
during the time between infection and 
detection of a viral antigen or antibody 
marker, or during the late stages of infection1. 
Allain reported OBI in several clinical 
contexts including: (1) recovery from past 
infection indicated by the presence of 
hepatitis B surface antibody (anti-HBs); (2) 
chronic hepatitis with surface gene escape 
mutants that are not recognized by current 
assays; (3) chronic carriage without any 
marker of HBV infection other than HBV 
DNA (referred to as, sero-negative,);  and (4) 
most commonly in endemic areas, chronic 
carriage stage with HBsAg too low to be 
detected and recognized by the presence of 
anti-HBc as the only serological marker 
(referred to as anti-HBc alone or isolated anti-
HBc) 6. 
H 
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Sudan is classified among countries with a 
high hepatitis B surface antigen (HBsAg) 
with endemicity of more than 8%7. Exposure 
to HBV infection ranges from 47% to 78% 
with HBsAg seroprevalence ranging from as 
low as 6.8%8 in central Sudan, to as high as 
26%  in southern Sudan9. Seroprevalence of 
HBsAg among asymptomatic blood donors 
ranged from 12.3% in southern Sudan to 
17.5% in central Sudan 7. 
The aim of this study is to identify the 
prevalence of occult HBV among screened 
HBsAg subjects in Gezira State Sudan.  
MATERIALS AND METHODS: 
This was a prospective, descriptive, hospital 
based study. HBsAg and HBV DNA were 
detected in 81 cancer patients, 95 of hospital 
based controls in addition to 69 Health care 
workers. All study subjects were recruited 
from Wadmedani Hospital, Gezira State, 
Sudan during 2008-2009. Ethical clearance 
was obtained from National cancer Institute 
Ethical Review committee. 
Detection of HBsAg: Five ml of venous 
blood was collected from each participant into 
an anti- coagulant EDTA-containing tube 
after written informed consent. HBV surface 
antigen (HBsAg) was detected by HBsAg 
ELISA Kit (Monolisa™ HBs Ag ULTRA, 
Marnes-la-Coquette-France) according to the 
manufacture instructions.  
Molecular Detection of HBV: Genomic 
DNA was extracted from the plasma samples 
using cinnaGenIncDNP™ Kit (DN 8115C) 
Tehran, Iran. HBV DNA was detected by 
Polymerase Chain Reaction (PCR), using 
cinnaGenIncDNP™ PCR Kit as 
recommended by the manufacturer. HBV 
Positive samples were identified by presence 
of a 353 bp PCR product by electrophoresis 
using 2% agarose gel. 
Statistical analysis: Data were expressed as 
mean and standard deviation (SD) as 
appropriate. Comparison between HBsAg and 
HBV DNA were performed using the Chi-
square test, and Fisher’s exact test as 
appropriate. Data were collected and 
analyzed. The Statistical Package for Social 
Science (SPSS version 16.0) was used in 
performance of all statistical analyses, and p-
value less than 0.05 was considered 
significant. 
RESULTS: 
A total number of 245 subjects were selected 
for this study as follows: 81 were cancer 
patients, 95 were hospital based controls and 
69 were health care workers. 
Occult HBV among cancer patients and 
hospital based controls: 176 subjects, 
including 81 cancer patients and 95 hospital 
based controls, were examined for HBsAg 
and the presence of HBV DNA. The study 
showed that 49/176 (27.8%) were positive for 
occult HBV as follows, cancer patients had 
31/81 (38.2%) cases, while 18.9% were 
reported among hospital based controls. 
11.2%, 2.2% were positive for both HBsAg 
and DNA respectively as shown in table (1).  
With respect to cancer patients 65.4% (53/81) 
were males and 34.6% (28/81) were females. 
Occult HBV was found in 41.5% (22/53) 
males’ cancer patients, while it was seen 
among 32.1% (9/28) females’ cancer patients. 
Regarding    hospital   based   controls;  males 
Table (1): Results of HBV in both cancer patients and hospital based controls (N=176). 
Type of subject 
  + ve HBV DNA 
  -veHBsAg 
  Occult HBV (%) 
+ve HBV DNA 
 +veHBsAg (%) 
 




Cancer patients   31 (38.2) 9 (11.2) 41 (50.6) 81(100) 
Hospital based control   18 (18.9) 2 (02.2) 75 (78.9) 95 (100) 
Total   49 (27.8) 11(06.3) 116 (65.9) 176 (100) 
Pearson Chi-Square Test P= .000 for HBV DNA 
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were 68.4% (65/95), while females were 
31.6% (30/95).  Among this group, Occult 
HBV was detected in 20.0% (6/30) of females 
and 18.5% (12/65) in males.  
Occult HBV among cancer patients 
washigher in all age groups range except 
among the group between 21-30 years as 
shown in table (2). 
In contrast to cancer patients, Occult HBV
was found to cluster among those less than 20 
years and those more than 60 in hospital 
based controls as shown in table (3). 
Occult HBV among Health Care Workers 
(HCW): Sixty nine of health care workers 
were screened for HBsAg. 27.5% (19/69) 
were found to be positive and 72.5% (50/69) 
of them were negative. The risk of acquisition 
of occult HBV was founded to be 
Table (2): Occult HBV among cancer patients according to age. 
Age range 
  -veHBsAg 
  + ve HBV DNA 
  Occult HBV (%) 
+veHBsAg 
+ve HBV DNA (%) 
 
-veHBsAg 
-ve HBV DNA (%) 
 
Total (%) 
>20   10 (38.5) 01 (03.8)  15 (57.7) 26 (100) 
21-30   01 (16.7) 03 (50.0) 02 (33.3) 06 (100) 
31-40   05 (50.0) 01 (10.0) 04 (40.0) 10 (100) 
41-50   05 (35.7) 01 (07.2) 08 (57.1) 14 (100) 
51-60   03 (33.3) 01 (11.1) 05 (55.6) 09 (100) 
<61   06 (37.50 02 (12.5) 08 (50.0) 16 (100) 
Total   31(38.2) 09 (11.2) 41(50.6) 81 
Fisher's Exact Test P= .9 for HBsAg P= .50 for HBV DNA 
Table (3): Occult HBV among Hospital based controls according to age. 
Age range 
  -veHBsAg 
  + ve HBV DNA 
  Occult HBV (%) 
+veHBsAg 
 +ve HBV DNA (%) 
 
-veHBsAg 
-ve HBV DNA (%) 
 
Total (%) 
>20   07 (26.9) 2 (07.7) 17 (65.4) 26 (100) 
21-30   03 (14.3) 00 (00.0) 18 (85.7) 21 (100) 
31-40   03 (21.4) 00 (00.0) 11 (78.6) 14 (100) 
41-50   02 (16.7) 00 (00.0) 10 (83.3) 12 (100) 
51-60   00 (00.0) 00 (00.0) 11 (100) 11 (100) 
<61   03 (27.3) 00 (00.0) 08(72.7) 11 (100) 
Total   18 (18.9) 2 (11.2) 75 (78.9) 95 
 
high among young subjects, who were less 
than 40 yrs, as shown in table (4).The 
duration of work and experience had a great 
role in HBV infection among Health Care 
Workers. Occult HBV was found more 
among those who worked less than one year 
and decreased with the increase of duration of 
work, as shown in table (5). 
DISCUSSION:                                       
Occult HBV infection OBI diagnosis is based 
upon detection of HBV DNA when HBsAg is 
absent. It is very important to define the 
optimal methodology to test this marker to 
prevent false positive results, depending on 
HBsAg assay sensitivity. The gold standard 
for OBI diagnosis is the study of extracted 
DNA (from liver or blood) 10. A total of 245 
subjects, including 176 cancer patients, and 
hospital based controls, and 69 health care 
workers, were examined for HBsAg and the 
presence of HBV DNA in this study. The 
results showed that occult infection was 
higher among cancer patients compared with 
the hospital based control (38.2%, and 18.9%, 
respectively). Occult HBV among Health care 
workers was 20%. Wong et al found that 73% 
of   patients  with   apparently    unidentifiable 
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Table (4): Distribution of occult HBV with age among health care workers. 
Age range 
  + ve HBV DNA 
  -veHBsAg 
  Occult HBV (%) 




  >20   01 (50.0) 01 (50.0) 02 (100) 
  21-30   06  (26.1) 17 (73.9) 23 (100) 
  31-40   02 (16.7) 10 (83.3) 12 (100) 
  41-50   01 (12.5) 07 (87.5) 08 (100) 
  51-60   00 04 (100) 04 (100) 
  <61   00 01 (100) 01 (100) 
Total   10 (20.0) 40 (80.0) 50 
Table (5): Distribution of occult HBV among HCW by duration of the work. 
Duration of the work  in 
years 
  + ve HBV DNA 
  -veHBsAg 
  Occult HBV (%) 




  1<   03 (42.9) 04 (57.1) 07 (100) 
  2-5   04 (28.6) 10 (71.4) 14 (100) 
  6-9   01 (14.3) 06 (85.7) 07 (100) 
  10-13   00 (00.0) 07 (100) 07 (100) 
  14-17   00 (00.0) 04 (100) 04 (100) 
  18-21   02 (25.0) 06 (75.0) 08 (100)  
  22-25   00 (00.0) 03 (100) 03 (100) 
Total   10 (20.0) 40 (80.0) 50 
 
causes for HCC were HBV-OBI related11. 
Cancer patients and health care worker are 
more susceptible for HBV infection than the 
hospital based control because they are at 
high risk of infection. 
Occult hepatitis B infection has a major 
impact on transfusion safety12. The standard 
test for detection of occult infection is the 
amplification of HBV DNA. However, the 
serological assay for the long lasting 
antibody response to the highly 
immunogenic HBV core antigen represents 
a qualified candidate as a surrogate for 
DNA amplification. The high prevalence of 
OBI among both hospital based control and 
health care worker was (18%), (20%) 
respectively, who make a good pool for 
blood donation. Hence the implementation 
of core antibody testing becomes important 
step towards continuous improvement in 
blood safety10.  
Many epidemiological and molecular 
studies had indicated that OBI is a potential 
risk factor for development of HCC and 
Non -Hodgkin’s lymphoma (NHL)13. In this 
Study, cancer patients who were less than 
20 years old had a high rate (38.9%) of 
Occult hepatitis B infection as compared to 
hospital based controls. This may suggest 
that that cancer patients may had maternal 
infection of HBV.A high percentage of OBI 
was found among health care workers who 
worked less than one year. This may 
suggest that the experience may play a role 
in protection against OBI. 
CONCLUSION: 
This study concluded that the prevalence of 
OBI among both healthcare workers and 
hospital based controls cancer patients is 
remarkable increasing compared with the 
prevalence of the disease. It recommended 
that a proper screening program for HBV 
has to be implemented so as to avoid the 
issue of OBI transmission. However further 
molecular genetics and prospective 
molecular epidemiological studies are 
needed to display the role of OBI in cancer 
diseases. 
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